In the overall HF subgroups, all four NOACs were at least equally effective or better in preventing stroke or systemic embolism, and factor Xa-inhibitors in particular demonstrated lower rates of major bleeding compared to VKA (Fig. 2) [26]. The gene discussed is F10; the disease is Stroke.